Page 2 of 2
12

2016 (4 POSTS)

Cetin K, Callaghan F, Fryzek JP, Bylsma LC, Bezold C, Mehta B. Safety and efficacy/effectiveness of second-line treatments in patients with Immune Thrombocytopenia: A systematic review of the literature. Presented at the Thrombosis & Hemostasis Summit of North America, Chicago, IL, April 2016

2015 (2 POSTS)

Shah F, Leung L, Barton HA, Will Y, Rodrigues AD, Greene N, Aleo MD. 2015. Setting clinical exposure levels of concern for drug-induced liver injury (DILI) using mechanistic in vitro assays. Toxicol Sci 147(2):500-14; doi: 10.1093/toxsci/kfv152. PMID: 26206150.

View Abstract

Bottomley A, Prior H, Cordes J. Global cross-company data-sharing on the housing of non-rodents during the recording of cardiovascular telemetry data on safety pharmacology and toxicology studies. Poster presented at Safety Pharmacology Society, Prague, September 2015.

2014 (2 POSTS)

Barat S, Robison TW. Information and report formats to facilitate safety qualifications. USP/PQRI/FDA Annual Meeting, 2014/2013.

Robison TW, Barat SA. Information and report formats to facilitate safety qualifications suitability and compatibility for packaging and delivery systems. Workshop Co- sponsored by USP and PQRI, USP Meetings Center, Rockville, Maryland, April 28, 2014.

2005 (1 POST)

Choksi NY, Allen DG, Inhof CJ, Truax JF, Tice RR, Stokes WS. Performance of BCOP, IRE, ICE, and HET-CAM in detecting substances that induce severe irritation and irreversible ocular damage. Presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

View Abstract

1999 (1 POST)

Cher DJ, Mrad RJ, Kelsh MA. 1999. Cellular telephone use and fatal traffic collisions: A commentary. Accid Anal Prev 31(5):599; doi: 10.1016/s0001-4575(99)00003-2. PMID: 10440557.

View Abstract
Page 2 of 2
12